Bipolar Disorder XI: Continuous Decline of Lithium Response Inversely Correlated to Time Before Drug Administration in Relation to Onset of a Bipolar Disorder
Per-Olof Nylander, Erik Lexne, Christer Lehman, Lars Brudin, Finn Bengtsson · 2026
Read Bipolar Disorder XI: Continuous Decline of Lithium Response Inversely Correlated to Time Before Drug Administration in Relation to Onset of a Bipolar Disorder by Per-Olof Nylander, Erik Lexne, Christer Lehman, Lars Brudin, Finn Bengtsson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13631887.txt.
Description
Per-Olof Nylander and four colleagues published this 2026 follow-up study on lithium treatment for bipolar disorder. Bipolar disorder brings repeated episodes of depression and unusually high mood. Lithium is a long-used drug for it, yet patients respond unevenly. The team studied one hundred ninety-two patients from lithium clinics and asked whether the wait before starting lithium predicted how well it worked.
Patients who began lithium soon after diagnosis responded better than those who started later. Response fell steadily as the gap between illness onset and treatment grew longer. Type I patients generally started lithium earlier than type II patients. Even so, the timing pattern held across both types. The authors argue that starting lithium early matters, and that delay itself may slowly reduce the drug's benefit.
Catalog record
| CREATOR | Per-Olof Nylander, Erik Lexne, Christer Lehman, Lars Brudin, Finn Bengtsson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43747 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |